Innovation Digest – April 2021 Vol. 2

Momentous change is emerging as the theme of 2021. In so many ways, that is both an energizing and a daunting opportunity. The conversation about health equity (as just one aspect of the historic dialogue happening now) is evolving to prioritize actions and outcomes that must become our new yardstick for quality, effectiveness and value. Transparency to the purchaser and the patient is on the rise, and this trend is exposing the sober realities of disjoint and even discriminatory pricing across the healthcare system. If we mean to have a patient-driven system that prioritizes and achieves health, these two areas are top of my list for hard conversations about how policy can better align incentives and drive market action. First, we must consider the unmet needs and lived experience of people that differ by age, gender, geography, socio-economic reality and community (race, ethnicity, culture, identity). Such inputs must drive innovation, research, delivery design and access to care. Second, such work must be inclusive of those communities from the beginning, with transparency of both processes and shared learning, in order to build trust and accelerate change.

In this issue:

  • It’s time to get health care value assessment right
  • Epic, Humana ramp up partnership to focus on streamlining prior authorizations
  • Reinventing the Center for Medicare and Medicaid Innovation
  • A Next Frontier In Health Care Transparency: Health Plan Drug Coverage Policy
  • Ethics Consult: Stop Treatment for Costly Patient? MD/JD Weighs In
  • Where hybrid work can’t work
  • Is the concept of ‘social determinants of health’ inhibiting progress toward equity?
Back to Viewpoint